| Statin therapy is associated with lower prevalence of gut microbiota dysbiosis S Vieira-Silva, G Falony, E Belda, T Nielsen, J Aron-Wisnewsky, ... Nature 581 (7808), 310-315, 2020 | 403 | 2020 |
| Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity R Chakaroun, M Raschpichler, N Klöting, A Oberbach, G Flehmig, M Kern, ... Metabolism 61 (5), 706-714, 2012 | 328 | 2012 |
| Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? R Chakaroun, L Massier, P Kovacs Nutrients 12 (4), 1082, 2020 | 260 | 2020 |
| Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology A Molinaro, P Bel Lassen, M Henricsson, H Wu, S Adriouch, E Belda, ... Nature Communications 11 (1), 5881, 2020 | 189 | 2020 |
| Combinatorial, additive and dose-dependent drug–microbiome associations SK Forslund, R Chakaroun, M Zimmermann-Kogadeeva, L Markó, ... Nature 600 (7889), 500-505, 2021 | 179 | 2021 |
| Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes L Massier, R Chakaroun, S Tabei, A Crane, KD Didt, J Fallmann, ... Gut 69 (10), 1796-1806, 2020 | 178 | 2020 |
| Microbiome and metabolome features of the cardiometabolic disease spectrum S Fromentin, SK Forslund, K Chechi, J Aron-Wisnewsky, R Chakaroun, ... Nature medicine 28 (2), 303-314, 2022 | 154 | 2022 |
| Long-term relapse of type 2 diabetes after Roux-en-Y gastric bypass: prediction and clinical relevance J Debédat, N Sokolovska, M Coupaye, S Panunzi, R Chakaroun, ... Diabetes Care 41 (10), 2086-2095, 2018 | 134 | 2018 |
| Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism E Belda, L Voland, V Tremaroli, G Falony, S Adriouch, KE Assmann, ... Gut 71 (12), 2463-2480, 2022 | 98 | 2022 |
| Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases L Massier, M Blüher, P Kovacs, RM Chakaroun Frontiers in Endocrinology 12, 616506, 2021 | 90 | 2021 |
| Di-(2-ethylhexyl)-phthalate (DEHP) causes impaired adipocyte function and alters serum metabolites N Klöting, N Hesselbarth, M Gericke, A Kunath, R Biemann, R Chakaroun, ... PLoS one 10 (12), e0143190, 2015 | 90 | 2015 |
| The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease RM Chakaroun, LM Olsson, F Bäckhed Nature Reviews Cardiology 20 (4), 217-235, 2023 | 74 | 2023 |
| Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability L Massier, R Chakaroun, P Kovacs, JT Heiker Gut 70 (9), 1801-1802, 2021 | 57 | 2021 |
| Dietary assessment in the MetaCardis study: development and relative validity of an online food frequency questionnaire EO Verger, P Armstrong, T Nielsen, R Chakaroun, J Aron-Wisnewsky, ... Journal of the Academy of Nutrition and Dietetics 117 (6), 878-888, 2017 | 52 | 2017 |
| Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques T Karlas, J Berger, N Garnov, F Lindner, H Busse, N Linder, A Schaudinn, ... World Journal of Gastroenterology: WJG 21 (16), 4894, 2015 | 51 | 2015 |
| Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity J Münzker, N Haase, A Till, R Sucher, SB Haange, L Nemetschke, T Gnad, ... Microbiome 10 (1), 96, 2022 | 48 | 2022 |
| The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception I Schamarek, L Anders, RM Chakaroun, P Kovacs, K Rohde-Zimmermann Nutrition journal 22 (1), 28, 2023 | 28 | 2023 |
| Microbially produced imidazole propionate is associated with heart failure and mortality A Molinaro, I Nemet, P Bel Lassen, R Chakaroun, T Nielsen, ... Heart Failure 11 (7), 810-821, 2023 | 27 | 2023 |
| Prebiotic diet changes neural correlates of food decision-making in overweight adults: a randomised controlled within-subject cross-over trial E Medawar, F Beyer, R Thieleking, SB Haange, U Rolle-Kampczyk, ... Gut 73 (2), 298-310, 2024 | 24 | 2024 |
| NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression S Wittrisch, N Klöting, K Mörl, R Chakaroun, M Blüher, AG Beck-Sickinger Molecular Metabolism 31, 163-180, 2020 | 22 | 2020 |
